StockData
Pharma-Bio Serv, Inc. logo

Pharma-Bio Serv, Inc. (PBSV) stock

PBSVOTCServices-Management Consulting ServicesFiscal year ends October 31
Financials through Q3 FY2026, quarter ended Jul 31, 2026Last filing: 10-Q on Sep 14, 2026Score 9/30
$0.48+0.08 (+20.00%)

Close on Oct 19, 2026Market cap $11.00MP/E 48.0Yield –

Pharma-Bio Serv total assets

Total assets on the balance sheet at the end of each period.

Pharma-Bio Serv's total assets was $11.44M at Jul 31, 2026. For fiscal 2025 it was $13.65M, down 16.2% from the year before. Over ten years it grew -5.5% a year on average. The highest annual figure on record is $29.92M in fiscal 2020.

Annual total assets

PeriodPeriod endValueChange
FY2025Oct 31, 2025$13.65M-16.2%
FY2024Oct 31, 2024$16.29M-18.1%
FY2023Oct 31, 2023$19.90M-3.6%
FY2022Oct 31, 2022$20.65M-13.7%
FY2021Oct 31, 2021$23.92M-20.0%
FY2020Oct 31, 2020$29.92M+12.3%
FY2019Oct 31, 2019$26.63M+4.9%
FY2018Oct 31, 2018$25.38M+13.5%
FY2017Oct 31, 2017$22.35M-6.9%
FY2016Oct 31, 2016$24.00M-0.6%
FY2015Oct 31, 2015$24.14M+4.0%
FY2014Oct 31, 2014$23.21M+9.1%
FY2013Oct 31, 2013$21.28M+35.3%
FY2012Oct 31, 2012$15.74M+45.0%
FY2011Oct 31, 2011$10.85M+65.5%
FY2010Oct 31, 2010$6.56M–

Quarterly total assets

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q3 FY2026CQ2 2026Jul 31, 2026$11.44M-15.8%
Q2 FY2026CQ1 2026Apr 30, 2026$11.50M-17.3%
Q1 FY2026CQ4 2025Jan 31, 2026$13.55M-15.7%
Q4 FY2025CQ3 2025Oct 31, 2025$13.65M-16.2%
Q3 FY2025CQ2 2025Jul 31, 2025$13.59M-16.7%
Q2 FY2025CQ1 2025Apr 30, 2025$13.90M-17.9%
Q1 FY2025CQ4 2024Jan 31, 2025$16.08M-16.4%
Q4 FY2024CQ3 2024Oct 31, 2024$16.29M-18.1%
Q3 FY2024CQ2 2024Jul 31, 2024$16.32M-19.6%
Q2 FY2024CQ1 2024Apr 30, 2024$16.92M-13.7%
Q1 FY2024CQ4 2023Jan 31, 2024$19.23M-8.0%
Q4 FY2023CQ3 2023Oct 31, 2023$19.90M-3.6%
Q3 FY2023CQ2 2023Jul 31, 2023$20.30M-0.2%
Q2 FY2023CQ1 2023Apr 30, 2023$19.62M-2.7%
Q1 FY2023CQ4 2022Jan 31, 2023$20.90M-12.6%
Q4 FY2022CQ3 2022Oct 31, 2022$20.65M-27.8%
Q1 FY2022CQ4 2021Jul 31, 2022$20.33M-27.1%
Q2 FY2022CQ1 2022Apr 30, 2022$20.16M-33.2%
Q4 FY2021CQ3 2021Oct 31, 2021$23.92M-20.0%
Q3 FY2021CQ2 2021Jul 31, 2021$28.59M-5.0%
Q2 FY2021CQ1 2021Apr 30, 2021$27.90M-2.6%
Q1 FY2021CQ4 2020Jan 31, 2021$30.20M+15.4%
Q4 FY2020CQ3 2020Oct 31, 2020$29.92M+12.3%
Q3 FY2020CQ2 2020Jul 31, 2020$30.10M+14.7%
Q2 FY2020CQ1 2020Apr 30, 2020$28.64M+11.6%
Q1 FY2020CQ4 2019Jan 31, 2020$26.16M+3.5%
Q4 FY2019CQ3 2019Oct 31, 2019$26.63M+4.9%
Q3 FY2019CQ2 2019Jul 31, 2019$26.25M+12.6%
Q2 FY2019CQ1 2019Apr 30, 2019$25.65M+14.0%
Q1 FY2019CQ4 2018Jan 31, 2019$25.28M+12.8%
Q4 FY2018CQ3 2018Oct 31, 2018$25.38M+13.5%
Q3 FY2018CQ2 2018Jul 31, 2018$23.31M+3.5%
Q2 FY2018CQ1 2018Apr 30, 2018$22.51M-0.2%
Q1 FY2018CQ4 2017Jan 31, 2018$22.41M-2.8%
Q4 FY2017CQ3 2017Oct 31, 2017$22.35M-6.9%
Q3 FY2017CQ2 2017Jul 31, 2017$22.51M-6.3%
Q2 FY2017CQ1 2017Apr 30, 2017$22.56M–
Q1 FY2017CQ4 2016Jan 31, 2017$23.06M–
Q4 FY2016CQ3 2016Oct 31, 2016$24.00M–
Q3 FY2016CQ2 2016Jul 31, 2016$24.02M–

More Pharma-Bio Serv figures

See a number that looks wrong?